NCT05554146Completed
Pain Inflammation and Cannabis in HIV
The Impact of Medical Cannabis on Pain and Inflammation in People Living With HIV
Source: ClinicalTrials.gov · Last updated 13 Nov 2025
Brief summary (registry, in English)
This study will examine how medical cannabis use affects neuropathic pain, inflammation and adverse events in people living with HIV (PLWH) with neuropathic pain. The investigators will observe how varying ratios of tetrahydrocannabinol (THC) and cannabidiol (CBD) in medical cannabis impact neuropathic pain, inflammation and adverse events.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 35 (actual)
- First submitted
- 21 Sept 2022
- Start date
- 28 Oct 2022
- Primary completion date
- 3 May 2024
- Lead sponsor
- Montefiore Medical Center
- Diseases
- HIV
- NCT number
- NCT05554146
What you commit to
- Study type: Interventional
- Participants enrolled: 35
- From 28 Oct 2022 to the primary completion date, 3 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current or prior psychotic disorder
- Non-steroidal anti-inflammatory use within 7 days prior to enrollment
- Steroid use within the past 14 days with duration of therapy \>=21 days
Other illness
- Terminal illness
- COVID vaccination or booster within 14 days of screening
- Active or acute cardiac disease based on clinician chart review.
Other
- Inability to provide informed consent
- Inability to complete 14 weeks of study visits
- Medical cannabis use within 14 days of enrollment, and no medical cannabis dispensed within 30 days of enrollment
- Unique pain symptoms (e.g., multiple sclerosis, rheumatoid arthritis)
- Unregulated cannabis use in the past 14 days; opioid or cocaine use in the past 30 days
- Dispensed opioids within 30 days
Who the study is looking for
- -\>=18 years old
- Diagnosis of HIV
- Fluency in English
- Active certification for medical cannabis
- ICD-10 diagnosis code for neuropathic pain, OR Neuropathic pain in problem list of electronic medical record, OR Neuropathic pain per medical cannabis certification form, OR Neuropathic Pain Questionnaire-Short Form\>0
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Montefiore Health System Coordinator of this site? Confirm its status | The Bronx | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.